Inogen
INGN
45 hedge funds and large institutions have $155M invested in Inogen in 2014 Q1 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
51.55% more ownership
Funds ownership: 0% → 51.55% (+52%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$96.4M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$8.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.11M |
| 4 |
DM
Deerfield Management
New York
|
+$6.35M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$5.43M |
Top Sellers
INGN Hedge Fund Activity: Q1 2014 in Review
45 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q1 2014, worth a combined $155M.
Buyers outnumbered sellers: 45 funds opened new INGN positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $96.4M.
- 45 institutional investors held Inogen (INGN) as of Q1 2014, up from 0 in Q4 2013.
- Funds reported $155M of Inogen stock for Q1 2014.
- 45 funds opened new Inogen positions in Q1 2014 and 0 closed out, a net change of +45 holders.
- The largest Inogen buyer in Q1 2014 was Novo Holdings A/S, an estimated $96.4M added.
Based on aggregated 13F filings for Q1 2014.